Table 2.
No. | Species | Breed | Age (y) | Sex 1 | Weight (kg) | Tumor Type | Tumor Site | Simultaneous Therapy | Fluorescence |
---|---|---|---|---|---|---|---|---|---|
1 | Dog | Minatare Schnauzer | 6 | M | 8 | Histiocytoma | Nasal planum | + | |
2 | Dog | Dogo Argentino | 9 | F | 30 | Mast cell tumor/Mast cell tumor | Skin | +/+ | |
3 | Dog | Chihuahua | 12 | SF | 2.8 | Transitional cell carcinoma | Nasal cavity | + | |
4 | Cat | American shorthair | 11 | F | 3.3 | Sebaceous gland carcinoma | Skin | + | |
5 | Cat | Mix | 11 | SF | 4.3 | Fibrosarcoma | Subcutis | N.A. 2 | |
6 | Cat | Mix | 8 | F | 4.6 | Mammary gland tumor | Mammary gland | + | |
7 | Cat | Mix | 13 | F | 4.5 | Mammary gland tumor | Lymph node | + | |
8 | Dog | Mix | 15 | M | 6.8 | Hemangiopericytoma | Skin | + | |
9 | Dog | Golden Retriever | 6 | CM | 30 | Myeloma | Calcaneus | Melphalan | N.A. |
10 | Dog | Mix | 12 | F | 21.3 | Adenocarcinoma | Paranasal sinus | Doxorubicin, Carboplatin | + |
11 | Dog | Mix | 11 | M | 17.4 | Transitional cell carcinoma | Lower urinary tract | Doxorubicin, Carboplatin | N.A. |
12 | Dog | Minatare Dachshund | 13 | SF | 4.2 | Adenocarcinoma | Nasal cavity | Lapatinib | + |
13 | Dog | Mix | 10 | M | 15 | Chondrosarcoma | Nasal cavity | Lapatinib | + |
14 | Dog | Minatare Dachshund | 9 | F | 3.6 | Inflammatory mammary gland tumor | Mammary gland | Lapatinib | - |
1 M, male; CM, castrated male; F, female; SF, spayed female; 2 N.A.: not available.